A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors

Clinical trial NCT03129139 · UNKNOWN

Trial details

NCT number: NCT03129139
Sponsor: Minneamrita Therapeutics LLC
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Gastric Cancer Breast Cancer Pancreatic Cancer Prostate Cancer Metastatic Colo-rectal Cancer Solid Tumor Solid Carcinoma Solid Carcinoma of Stomach Cancer of Stomach

Start date: 2017-10-10
Primary completion: 2024-06-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.